This week, AdvaMed, the Medtech Association, praised ongoing legislative efforts to develop a pathway for Medicare coverage for FDA-approved Breakthrough Technologies during a House Committee on Energy and Commerce Subcommittee on Health hearing. “For many Medicare patients, access to FDA-approved breakthrough medical technologies is a matter of life and death, making a predictable pathway for CMS coverage of these devices a top priority for AdvaMed and our industry. Patients simply cann...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=308342